Chronic cough, a persistent and often debilitating condition, presents a clinical challenge for healthcare professionals worldwide. Despite its prevalence, the etiology remains poorly understood, necessitating a comprehensive approach to diagnosis and treatment.
Chronic cough is multifactorial, with common causes including gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, a significant proportion of patients do not respond to treatment for these conditions, indicating a complex underlying etiology.
A thorough patient history and physical examination form the cornerstone of diagnosis. However, additional investigations such as chest X-rays, spirometry, and bronchoscopy may be required in certain cases. Empirical therapy based on the most likely cause can also be a useful diagnostic tool.
Treatment should be tailored to the identified cause. For GERD-related cough, proton pump inhibitors may be effective. Inhaled corticosteroids are often beneficial for asthma-related cough, while antihistamines and decongestants can alleviate UACS-related symptoms. In refractory cases, novel therapies such as speech therapy and neuromodulators are showing promise.
Effective patient education is crucial in managing chronic cough. Patients should be informed about the potential causes and treatment options, and reassured that serious underlying conditions are rare. They should also be encouraged to avoid cough triggers and adhere to prescribed therapies.
Chronic cough, while common, remains an enigmatic condition. A comprehensive approach, incorporating a detailed clinical evaluation, targeted treatment, and effective patient education, is essential for optimal management. As our understanding of chronic cough continues to evolve, healthcare professionals must stay abreast of emerging diagnostic tools and treatment strategies to provide the best possible care for their patients.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation